BGM
GH icon

Burkehill Global Management’s Guardant Health GH Stock Holding History

Burkehill Global Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-150,000
Closed -$13.9M – 190
2026
Q1 		$13.9M Hold
150,000
– – 0.69% 34
2025
Q4 		$15.3M Buy
+150,000
New +$13.4M 1.01% 34

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Burkehill Global Management's GH Position: Q2 2026 in Review

Burkehill Global Management sold out of Guardant Health (GH) in Q2 2026, closing a stake of 150,000 shares — an estimated $13.9M sold.

Burkehill Global Management first reported a position in GH in Q4 2025 and held it in 2 quarters. The position peaked at $15.3M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Burkehill Global Management reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Burkehill Global Management sold 150,000 Guardant Health shares in Q2 2026, an estimated $13.9M.
  • Burkehill Global Management first reported a position in Guardant Health in Q4 2025 and held it in 2 quarters.
  • Burkehill Global Management's Guardant Health position peaked at $15.3M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.